Data / Form D filings / NEW AMSTERDAM SCIENCES, INC.
NEW AMSTERDAM SCIENCES, INC.: Form D filing
NEW AMSTERDAM SCIENCES, INC., a biotechnology company in Scottsdale, AZ, filed a Form D with the SEC in 2015. The latest, on November 19, 2015, reports $250,000 sold of a $2 million offering to 3 investors.
Find out what NEW AMSTERDAM SCIENCES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14362 NORTH FRANK LLOYD WRIGHT BLVD., SUITE 1000, Scottsdale, AZ, 85260
- Phone
- (480) 477-7735
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1656189
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 19, 2015 | New notice | $2,000,000 | $250,000 | $1,750,000 | 3 | Oct 6, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael K. Wilhelm | Executive Officer | |
| Jerry K. Toepfer | Executive Officer | |
| Hal N. Siegel, PhD. | Executive Officer |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Nov 16, 2015 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEW AMSTERDAM SCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.